Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More

Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More
Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…
Read More
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…
Read More
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
In the rapidly evolving landscape of life sciences, Polymerase Chain Reaction (PCR) stands as a foundational molecular biology technique, indispensable…
Read More
Sai Life Sciences recently convened its highly anticipated Biotech Pitch Day 2026 at its strategically located Boston-area site, gathering a…
Read More
The American Association for Cancer Research (AACR) Annual Meeting, held this year in San Diego, CA, USA, from April 17–22,…
Read More
Boston, MA – Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly…
Read More